Cytomedix Announces Proposed National Coverage Determination Memo by CMS for Autologous PRP Gel in Chronic Wound Care

Cytomedix announced that the Centers for Medicare & Medicaid SERvices issued a proposed National Coverage Determination memo for autologous blood-derived products for chronic non-healing wounds.... [more]

View complete Press Release article